Your shopping cart is currently empty

BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes. |
| In vitro | BR102375 (Compound 18) (10 μM) enhances gene expression related to PPARγ activation and improves glucose uptake with insulin stimulation. Additionally, BR102375 (10 nM, 100 nM, 1 μM; 6 days, 14 days) exhibits concentration-dependent, insulin-sensitive effects on adipogenesis [1]. |
| In vivo | BR102375 demonstrates efficacy in a mouse diabetes model, significantly suppressing the rise in random blood glucose levels (75 mpk, p.o., bid) and showing a decent effect on insulin resistance during the Oral Glucose Tolerance Test (OGTT). Additionally, it exhibits results on body weight gain that are nearly identical to those of Pioglitazone [1]. |
| Molecular Weight | 554.64 |
| Formula | C31H34N6O4 |
| Cas No. | 2366255-59-4 |
| Smiles | O=C1NC(C2=C(C=CC=C2)C3=CC=C(CN4C(CCCC)=NC(C)=C(CC5=NC(C(C)(C)C)=NO5)C4=O)C=C3)=NO1 |
| Relative Density. | 1.28 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.